89 related articles for article (PubMed ID: 1866076)
1. Biocompatibility of PMMA membranes used in haemofiltration and haemodiafiltration: beta 2-microglobulin removal and release of granulocyte elastase.
Hillion D; Haas T; Uzan M; Pertuiset N; Beyne P
Nephrol Dial Transplant; 1991; 6 Suppl 2():84-5. PubMed ID: 1866076
[No Abstract] [Full Text] [Related]
2. The rôle of adsorption in beta 2-microglobulin removal.
David S; Canino F; Ferrari ME; Cambi V
Nephrol Dial Transplant; 1991; 6 Suppl 2():64-8. PubMed ID: 1866072
[TBL] [Abstract][Full Text] [Related]
3. Haemodiafiltration versus paired filtration dialysis: evaluation of in vivo solute removal.
Bufano G; Ariano R; Pecchini P; Pecchini F
Nephrol Dial Transplant; 1991; 6 Suppl 2():82-3. PubMed ID: 1866075
[No Abstract] [Full Text] [Related]
4. Biocompatibility and capability of haemopurification systems: review and future development.
Ota K
Nephrol Dial Transplant; 1991; 6 Suppl 2():86-90. PubMed ID: 1866077
[TBL] [Abstract][Full Text] [Related]
5. Beta 2-microglobulin kinetics during haemofiltration.
Floege J; Wilks M; Shaldon S; Koch KM; Smeby LC
Nephrol Dial Transplant; 1988; 3(6):784-9. PubMed ID: 3147420
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a new high-flux cellulose acetate membrane.
Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
[TBL] [Abstract][Full Text] [Related]
7. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
[TBL] [Abstract][Full Text] [Related]
8. Long-term multicentre study on beta 2-microglobulin removal by PMMA BK membrane.
Arakawa M
Nephrol Dial Transplant; 1991; 6 Suppl 2():69-74. PubMed ID: 1866073
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of three haemodialysers containing PMMA membranes of different surface area, with special attention to thrombogenicity.
Falkenhagen D; Brown GS
Nephrol Dial Transplant; 1991; 6 Suppl 2():43-8. PubMed ID: 1830939
[No Abstract] [Full Text] [Related]
10. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes].
Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H
Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346
[TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
12. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
[TBL] [Abstract][Full Text] [Related]
13. beta 2-Microglobulin and granulocyte elastase.
Wehle B; Bergstrom J; Kishimoto T; Lantz B; Levin N; Klinkmann H
Nephrol Dial Transplant; 1993; 8 Suppl 2():20-4. PubMed ID: 8272248
[TBL] [Abstract][Full Text] [Related]
14. Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration.
Lindström V; Grubb A; Alquist Hegbrant M; Christensson A
Scand J Clin Lab Invest; 2008; 68(8):685-91. PubMed ID: 18609120
[TBL] [Abstract][Full Text] [Related]
15. [Biocompatibility of synthetic membrane for blood purification therapy].
Akizawa T; Nabeshima K; Kawabe S
Nihon Rinsho; 1991 Dec; 49 Suppl():53-60. PubMed ID: 1808312
[No Abstract] [Full Text] [Related]
16. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
Montali U; Pilone N; Cioni L; Ronca G
Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
[TBL] [Abstract][Full Text] [Related]
17. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
[TBL] [Abstract][Full Text] [Related]
18. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
[TBL] [Abstract][Full Text] [Related]
19. [Dialysis amyloidosis and beta-2-microglobulin].
Sulková S; Votruba T
Cas Lek Cesk; 1989 Jan; 128(3):68-73. PubMed ID: 2655913
[TBL] [Abstract][Full Text] [Related]
20. Comparison of various treatment modes in terms of beta 2-microglobulin removal: hemodialysis, hemofiltration, and push/pull HDF.
Shinzato T; Kobayakawa H; Maeda K
Artif Organs; 1989 Feb; 13(1):66-70. PubMed ID: 2653287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
